FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...
New AAV therapy for retinitis pigmentosa completes Phase I/II dosing, aiming to protect cones and slow vision loss; first ...
The irregular, swirling motion of fluids we call turbulence can be found everywhere, from stirring in a teacup to currents in ...
Globally recognized pharmacoepidemiologist brings decades of experience advancing real-world evidence for regulatory decision-making.
A new report from Canada Sports Betting found that Ohio has a 1.13% chance of being abducted by aliens, with over 4,000 ...
Archaeology offers an unparalleled material record of urban dynamics, spanning thousands of years and operating in varied ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ...
Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...
The report, now featured on the mytsv.com blog, combines longitudinal data with a series of futuristic visualizations to explore why people born before 1940 possess physical health markers superior to ...
An Exploratory, Visual and Comparative Data Analysis on the Different Rates of Infection and Death due to COVID-19 in European and South Asian Countries. This repository contains the R code developed ...
Doctorate in Translational Biotechnology, Center for Biotechnology of Natural Resources, Universidad Catolica del Maule, Talca 3480094, Chile Laboratory of Bioinformatics and Computational Chemistry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results